Transcranial Magnetic Stimulation Therapy, or TMS therapy, is an accredited FDA stress treatment that uses magnetic pulses to activate some parts of the brain that are associated with depression and other forms of mood disorders. Because it is non-invasive and non-pharmacological, TMS provides an alternative for patients who have not improved their depression with other types of antidepressant treatments. Such conventional therapeutic treatments, such as prescription medications and complementary ways of curing depression, are not for all and will impact people differently. Visit FLORIDA TMS CLINIC.
Depression was termed the mental health “common cold.” An approximate 50 million Americans are suffering depressive symptoms, with repercussions in all aspects of life. Although there are a number of antidepressant medicines available, not all patients with depression respond to those treatments. Because it acts directly on the brain itself, TMS therapy can target specific mood- and energy-related areas while bypassing the side effects of typical antidepressant drugs such as weight gain, memory loss, low libido, insomnia and dry mouth. TMS specifically targets the region of the issue, whereas general antidepressant medicinal products come with more side effects.
Magnetic Transcranial Relaxation Treatment
The rhythmic, repeated electrical stimuli are delivered to the brain during Transcranial Magnetic Stimulation Therapy, typically in the prefrontal cortex. These pulses stimulate nerve cells in that region, controlling the firing of mood-regulating neurons which can trigger depression to be under-active.
Most people with chronic depression benefit from TMS therapy, not just those who fail to respond to antidepressants. TMS treatment outcomes include improved mood, increased energy and a more positive outlook. TMS is an excellent alternative to electro-seizure therapy (ECT), since it is non-invasive and does not result in memory loss.
TMS treatment sessions usually last under an hour. For maximum improvement, TMS therapists recommend a course of five sessions per week over four to six weeks.
The Food and Drug Administration has approved the use of TMS therapy for use primarily in the treatment of depression in adults whose condition after using one prior antidepressant did not improve. TMS is safe, but those with implanted near-head medical devices, such as pacemakers, stents, and shunts, may not be candidates for TMS treatment.